Details

Autor(en) / Beteiligte

• Andrade, Jason G
• Deyell, Marc W
• Khairy, Paul
• Champagne, Jean
• Leong-Sit, Peter
• Novak, Paul
• Sterns, Lawrence
• Roux, Jean-Francois
• Sapp, John
• Bennett, Richard
• Bennett, Matthew
• Hawkins, Nathaniel
• Sanders, Prashanthan
• Macle, Laurent

Titel

Atrial fibrillation progression after cryoablation vs. radiofrequency ablation: the CIRCA-DOSE trial

Ist Teil von

• European heart journal, 2024-02, Vol.45 (7), p.510-518

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2024

Link zum Volltext

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Background and Aims Atrial fibrillation (AF) is a chronic progressive disorder. Persistent forms of AF are associated with increased rates of thromboembolism, heart failure, and death. Catheter ablation modifies the pathogenic mechanism of AF progression. No randomized studies have evaluated the impact of the ablation energy on progression to persistent atrial tachyarrhythmia. Methods Three hundred forty-six patients with drug-refractory paroxysmal AF were enrolled and randomly assigned to contact-force–guided RF ablation (CF-RF ablation, 115), 4 min cryoballoon ablation (CRYO-4, 115), or 2 min cryoballoon ablation (CRYO-2, 116). Implantable cardiac monitors placed at study entry were used for follow-up. The main outcome was the first episode of persistent atrial tachyarrhythmia. Secondary outcomes included atrial tachyarrhythmia recurrence and arrhythmia burden on the implantable monitor. Results At a median of 944.0 (interquartile range [IQR], 612.5–1104) days, 0 of 115 patients (0.0%) randomly assigned to CF-RF, 8 of 115 patients (7.0%) assigned to CRYO-4, and 5 of 116 patients (4.3%) assigned to CRYO-2 experienced an episode of persistent atrial tachyarrhythmia (P = .03). A documented recurrence of any atrial tachyarrhythmia ≥30 s occurred in 56.5%, 53.9%, and 62.9% of those randomized to CF-RF, CRYO-4, and CRYO-2, respectively; P = .65. Compared with that of the pre-ablation monitoring period, AF burden was reduced by a median of 99.5% (IQR 94.0%, 100.0%) with CF-RF, 99.9% (IQR 93.3%–100.0%) with CRYO-4, and 99.1%% (IQR 87.0%–100.0%) with CRYO-2 (P = .38). Conclusions Catheter ablation of paroxysmal AF using radiofrequency energy was associated with fewer patients developing persistent AF on follow-up. Structured Graphical Abstract Structured Graphical abstract Atrial fibrillation progression after cryoablation versus radiofrequency ablation. AF, atrial fibrillation; AFL, atrial flutter; AT, atrial tachycardia; PVI, pulmonary vein isolation; CF-RF, standard RF ablation guided by tissue contact force; CRYO-4–4-minute, cryoballoon ablation duration; CRYO-2–2-minute, cryoballoon ablation duration.